Not a traditional drug phase: High Intensity Rehabilitation for Aging
This pilot study will measure the feasibility of a supplemental mobility intervention, the Safe Transfers And Mobility Program (STAMP). This program will be implemented in patients admitted to skilled nursing facilities (SNFs) following hospitalization.
Official registry: https://clinicaltrials.gov/study/NCT07872384 · University of Colorado, Denver · enrollment listed as 192
What this phase means
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are High Intensity Rehabilitation, Safe Transfers and Mobility Program, or Usual Care. The registry lists allocation as randomized. This pilot study will measure the feasibility of a supplemental mobility intervention, the Safe Transfers And Mobility Program (STAMP).
They plan to enroll about 192 people at 2 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Improving Functional Recovery in Skilled Nursing Facilities Through Supplemental Mobility
Interventions: High Intensity Rehabilitation, Safe Transfers and Mobility Program, Usual Care
Primary outcome (registry wording): Usual Gait Speed
Who it is for (from inclusion criteria)
- Ages 50 Years to any
- At least 50 years old
- Admitted to SNF from the hospital
- Ambulatory at admission with minimal assistance or less
Who the registry excludes
- Contraindications to high-intensity resistance training (per American College of Sports Medicine Exercise Testing and Prescription)
- Neurological diagnosis (e.g., cerebral vascular accident, multiple sclerosis, Parkinson's disease, traumatic brain injury)
- Lower extremity weight-bearing precautions that require greater than minimal assistance with ambulation
- Subsequent SNF admission
Contact
No central phone on the registry card. Use the official listing to reach a site.
Sites listed on ClinicalTrials.gov
2 listed- University of Colorado Denver, Anschutz Medical Campus — Aurora, Colorado (not_yet_recruiting)
- Aegis Therapies — Frisco, Texas (recruiting)
FAQ about this NCT record
Is NCT07872384 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT07872384?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT07872384?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary